Cargando…
Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1
[Image: see text] We describe our work to establish structure- and fragment-based drug discovery to identify small molecules that inhibit the anti-apoptotic activity of the proteins Mcl-1 and Bcl-2. This identified hit series of compounds, some of which were subsequently optimized to clinical candid...
Autores principales: | Murray, James B., Davidson, James, Chen, Ijen, Davis, Ben, Dokurno, Pawel, Graham, Christopher J., Harris, Richard, Jordan, Allan, Matassova, Natalia, Pedder, Christopher, Ray, Stuart, Roughley, Stephen D., Smith, Julia, Walmsley, Claire, Wang, Yikang, Whitehead, Neil, Williamson, Douglas S., Casara, Patrick, Le Diguarher, Thierry, Hickman, John, Stark, Jerome, Kotschy, András, Geneste, Olivier, Hubbard, Roderick E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6648477/ https://www.ncbi.nlm.nih.gov/pubmed/31459977 http://dx.doi.org/10.1021/acsomega.9b00611 |
Ejemplares similares
-
The Effect of Core Replacement on S64315, a Selective
MCL-1 Inhibitor, and Its Analogues
por: Sipos, Szabolcs, et al.
Publicado: (2021) -
S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth
por: Casara, Patrick, et al.
Publicado: (2018) -
Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures
por: Baker, Lisa M., et al.
Publicado: (2020) -
Exploring IDP–Ligand Interactions: Tau K18 as a Test Case
por: Vagrys, Darius, et al.
Publicado: (2020) -
Inhibition of Antiapoptotic BCL-XL, BCL-2, and MCL-1 Proteins by Small Molecule Mimetics
por: Dalafave, D.S., et al.
Publicado: (2010)